tradingkey.logo

Treace Medical Concepts Inc

TMCI

5.610USD

+0.270+5.06%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
353.25MCap. mercado
PérdidaP/E TTM

Treace Medical Concepts Inc

5.610

+0.270+5.06%
Más Datos de Treace Medical Concepts Inc Compañía
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Información de la empresa
Símbolo de cotizaciónTMCI
Nombre de la empresaTreace Medical Concepts Inc
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace
Número de empleados477
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 23
Dirección100 Palmetto Park Place
CiudadPONTE VEDRA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal32081
Teléfono19043735940
Sitio Webhttps://www.treace.com/
Símbolo de cotizaciónTMCI
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
72.42K
+85.77%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
53.38K
+12.38%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
72.42K
+85.77%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
53.38K
+12.38%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Treace (John T.)
18.61%
Armistice Capital LLC
9.87%
BlackRock Institutional Trust Company, N.A.
5.41%
William Blair Investment Management, LLC
4.93%
The Vanguard Group, Inc.
4.30%
Other
56.88%
Accionistas
Accionistas
Proporción
Treace (John T.)
18.61%
Armistice Capital LLC
9.87%
BlackRock Institutional Trust Company, N.A.
5.41%
William Blair Investment Management, LLC
4.93%
The Vanguard Group, Inc.
4.30%
Other
56.88%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
25.90%
Investment Advisor/Hedge Fund
21.15%
Investment Advisor
19.72%
Hedge Fund
17.61%
Research Firm
3.05%
Bank and Trust
0.34%
Sovereign Wealth Fund
0.10%
Pension Fund
0.04%
Insurance Company
0.03%
Other
12.07%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
369
55.31M
87.93%
-19.85M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
2023Q1
265
55.41M
90.97%
+228.07K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Treace (John T.)
11.70M
18.61%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.21M
9.87%
+2.00K
+0.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.40M
5.41%
+14.71K
+0.43%
Mar 31, 2025
William Blair Investment Management, LLC
3.06M
4.87%
+121.76K
+4.14%
Mar 31, 2025
The Vanguard Group, Inc.
2.71M
4.3%
-27.56K
-1.01%
Mar 31, 2025
CIBC Private Wealth Management
2.29M
3.65%
+405.26K
+21.46%
Mar 31, 2025
Gagnon Securities LLC
2.71M
4.31%
+963.43K
+55.16%
May 09, 2025
Treace (James T)
1.78M
2.83%
--
--
Mar 24, 2025
JP Morgan Asset Management
1.40M
2.22%
-93.94K
-6.29%
Mar 31, 2025
DWS Investments UK Limited
1.28M
2.04%
-4.96K
-0.39%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares U.S. Medical Devices ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Global X Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver más
Franklin US Small Cap Multifactor Index ETF
Proporción0.04%
iShares U.S. Medical Devices ETF
Proporción0.03%
Fidelity Enhanced Small Cap ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.02%
Global X Russell 2000 ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI